<DOC>
	<DOCNO>NCT01910363</DOCNO>
	<brief_summary>To test safety efficacy new generation botulinum toxin preparation A2NTX treat stroke patient low limb spasticity . - study degree spasticity ankle knee joint , walk speed 30 patient stroke inject 300 unit BOTOX A2NTX blind manner patient , physician , examiner . - also assess safety A2NTX compare BOTOX .</brief_summary>
	<brief_title>Study New Generation Botulinum Toxin A2NTX Treat Spasticity After Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>patient low limb spasticity stroke duration 6 month Modified Ashworth Scale ankle joint 2 patient previous botulinum toxin injection low limbs patient serious hepatic , renal cardiac dysfunction patient respiratory failure patient understand instruction</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>poststroke spasticity</keyword>
	<keyword>low limb</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>A2</keyword>
</DOC>